BOLALARDA IDIOPATIK TROMBOSITOPENIK PURPURA: LABORATORIYAVIY VA KLINIK KUZATUV

To’ymurodova Zarinabonu Elmurod qizi

Buxoro davlat tibbiyot instituti gematologiya va transfuziologiya kafedrasi 1-kurs magistranti

Keywords: Idiopatik trombositopenik purpura, ITP, bolalar, trombotsitlar soni, gemostaz parametrlar, laboratoriyaviy kuzatuv, klinik kuzatuv.

---

Abstract

Ushbu maqolada bolalarda idiopatik trombositopenik purpura (ITP) bilan bog‘liq laboratoriyaviy va klinik kuzatuvlar tahlil qilingan. Tadqiqot natijalari shuni ko‘rsatdiki, trombotsitlar soni, gemostaz parametrlar va boshqa laborator ko‘rsatkichlar bemorning klinik holatini baholashda muhim diagnostik vosita hisoblanadi. Klinik kuzatuvlar esa qon ketish xavfi va kasallik kechishining og‘irligini aniqlashga yordam beradi. Laboratoriyaviy va klinik kuzatuvlarni birgalikda baholash pediatrik ITPni samarali diagnostika qilish, davolashni individualizatsiya qilish va asoratlarning oldini olishda katta ahamiyatga ega.

---

References

1. Neunert C. E., Lim W., Crowther M., et al. The American Society of Hematology

2019 guidelines for immune thrombocytopenia. Blood, 2019;133(5): 540–558.

2. Provan D., Arnold D. M., Bussel J. B., et al. Updated international consensus

report on the investigation and management of primary immune

thrombocytopenia. Blood Advances, 2019;3(22): 3780–3817.

3. Imbach P., Barandun S., D’Apuzzo V., et al. High-dose intravenous

gammaglobulin for idiopathic thrombocytopenic purpura in childhood. The

Lancet, 1981;1: 1228–1231.

4. Bussel J., Kuter D., George J. Immune thrombocytopenia: diagnosis and

management guidelines. Hematology/Oncology Clinics of North America,

2004;18(6): 1267–1286.

5. Blanchette V., Key N., Lakshmanan A., et al. Guidelines for the management of

childhood ITP. Pediatric Blood & Cancer, 2003;41(3): 145–153.

6. Rodeghiero F., Stasi R., Gernsheimer T., et al. Standardization of terminology,

definitions and outcome criteria in immune thrombocytopenic purpura of adults

and children: report from an international working group. Blood, 2009;113(11):

2386–2393.

7. Cines D. B., Blanchette V. S. Immune thrombocytopenic purpura. New England

Journal of Medicine, 2002;346: 995–1008.

8. Neunert C., Terrell D. R., Arnold D. M., et al. American Society of Hematology

2011 evidence-based practice guideline for immune thrombocytopenia. Blood,

2011;117(16): 4190–4207.

9. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura.

Seminars in Hematology, 2000;37: 5–9.

10.Bussel J. B., Saleh M. N. Thrombopoietin receptor agonists in immune

thrombocytopenia: a review. British Journal of Haematology, 2008;143: 336–

348.